NEW YORK (360Dx) – GE, the Global Good Fund, and Access Bio today announced a licensing agreement to manufacture and distribute diagnostic technologies aimed at rapidly identifying asymptomatic malaria in low-resource nations.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.